Halozyme Therapeutics, Inc. (HALO)
63.89
+0.44
(+0.69%)
USD |
NASDAQ |
Dec 16, 13:41
Halozyme Therapeutics Accounts Payable (Quarterly): 15.36M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Merck & Co., Inc. | 4.147B |
| ANI Pharmaceuticals, Inc. | 69.80M |
| Bristol Myers Squibb Co. | 4.288B |
| Johnson & Johnson | 9.625B |
| AIM ImmunoTech, Inc. | 1.252M |